Share Your Experience to PRotect Patient Safety

Take the benchmarking survey on High Value Medical Products Transported in Small Quantities via Parcel Shipping.

• Estimated time to completion: approximately 5 minutes
• Intent: to provide data for a whitepaper focused on benchmarking operational practices for shipping high-value medical products in small quantities
• Background: “Specialty” medications (including cell & gene therapies, orphan drugs, and mRNA/mDNA products) represent approximately 2-3% of total prescriptions dispensed, while accounting for 50% or more of prescription drug sales (per IQVIA). Given demographic changes and an aging population, “specialty” product growth is anticipated to continue and accelerate. These products are typically very expensive and shipped in small quantities and often require temperature controls. Given the increased volume and critical-nature of these medical products, Rx-360 seeks your input in this survey to understand current organizational practices for shipping these high-dollar products.